Role of the Perfluorocarbon Fluosal-DA in Coronary Angioplasty
- 1 March 1994
- journal article
- review article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 307 (3) , 218-221
- https://doi.org/10.1097/00000441-199403000-00009
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Myocardial protection by perfluorochemical infusion during transient ischemia produced by balloon coronary occlusionAmerican Heart Journal, 1988
- Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20%.Circulation, 1986
- Fluosol-DA as a Red-Cell Substitute in Acute AnemiaNew England Journal of Medicine, 1986
- Usefulness of intracoronary infusion of fluorocarbon distal to prolonged coronary occlusion by angioplasty balloon in dogsThe American Journal of Cardiology, 1986
- Distal coronary artery perfusion during percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1985
- O2 and CO2 Solubility of the Fluorocarbon Emulsion Fluosol-DA 20% and O2 and CO2 Dissociation Curves of Blood — Fluosol-DA 20% MixturesPublished by Springer Nature ,1985
- Effects of fluorocarbons with and without oxygen supplementation on cardiac hemodynamics and energeticsThe American Journal of Cardiology, 1984
- Excretion of perfluorochemicals after intravenous injection of their emulsion.CHEMICAL & PHARMACEUTICAL BULLETIN, 1975
- Erythrocyte Substitute for Perfusion of BrainNature, 1967
- Survival of Mammals Breathing Organic Liquids Equilibrated with Oxygen at Atmospheric PressureScience, 1966